{
  "ticker": "REGN",
  "last_updated": "2025-04-19T10:04:54.704574",
  "retention_years": 3,
  "count": 949,
  "transactions": [
    {
      "id": 263880,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 263884,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17748"
    },
    {
      "id": 263903,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 263923,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "620"
    },
    {
      "id": 263931,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 263944,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1559"
    },
    {
      "id": 263963,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 263967,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6548"
    },
    {
      "id": 263971,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 305148,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 305152,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17748"
    },
    {
      "id": 305171,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 305191,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "620"
    },
    {
      "id": 305199,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 305212,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1559"
    },
    {
      "id": 305231,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 305235,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6548"
    },
    {
      "id": 305239,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 350872,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 350876,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17748"
    },
    {
      "id": 350895,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 350915,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "620"
    },
    {
      "id": 350923,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 350936,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1559"
    },
    {
      "id": 350955,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 350959,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6548"
    },
    {
      "id": 350963,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 398540,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 398544,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17748"
    },
    {
      "id": 398563,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "448"
    },
    {
      "id": 398583,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "620"
    },
    {
      "id": 398591,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 398604,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1559"
    },
    {
      "id": 398623,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 398627,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6548"
    },
    {
      "id": 398631,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-02",
      "transaction_shares": "166",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1548"
    },
    {
      "id": 263939,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-31",
      "transaction_shares": "3338",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "29610"
    },
    {
      "id": 305207,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-31",
      "transaction_shares": "3338",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "29610"
    },
    {
      "id": 350931,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-31",
      "transaction_shares": "3338",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "29610"
    },
    {
      "id": 398599,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-31",
      "transaction_shares": "3338",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "29610"
    },
    {
      "id": 263945,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-20",
      "transaction_shares": "14",
      "transaction_price": "0.0",
      "transaction_type": "W",
      "shares_after_transaction": "2186"
    },
    {
      "id": 305213,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-20",
      "transaction_shares": "14",
      "transaction_price": "0.0",
      "transaction_type": "W",
      "shares_after_transaction": "2186"
    },
    {
      "id": 350937,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-20",
      "transaction_shares": "14",
      "transaction_price": "0.0",
      "transaction_type": "W",
      "shares_after_transaction": "2186"
    },
    {
      "id": 398605,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-20",
      "transaction_shares": "14",
      "transaction_price": "0.0",
      "transaction_type": "W",
      "shares_after_transaction": "2186"
    },
    {
      "id": 228266,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-16",
      "transaction_shares": "304",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "48829"
    },
    {
      "id": 228269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-16",
      "transaction_shares": "1054",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "49074"
    },
    {
      "id": 228284,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-16",
      "transaction_shares": "702",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "30075"
    },
    {
      "id": 228286,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "969",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "34792"
    },
    {
      "id": 228297,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "759",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "14230"
    },
    {
      "id": 228312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-16",
      "transaction_shares": "298",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "4664"
    },
    {
      "id": 228349,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-16",
      "transaction_shares": "491",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "16265"
    },
    {
      "id": 263877,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-16",
      "transaction_shares": "304",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "48829"
    },
    {
      "id": 263881,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-16",
      "transaction_shares": "1054",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "49074"
    },
    {
      "id": 263897,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-16",
      "transaction_shares": "702",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "30075"
    },
    {
      "id": 263899,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "969",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "34792"
    },
    {
      "id": 263911,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "759",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "14230"
    },
    {
      "id": 263927,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-16",
      "transaction_shares": "298",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "4664"
    },
    {
      "id": 263970,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-16",
      "transaction_shares": "491",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "16265"
    },
    {
      "id": 305145,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-16",
      "transaction_shares": "304",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "48829"
    },
    {
      "id": 305149,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-16",
      "transaction_shares": "1054",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "49074"
    },
    {
      "id": 305165,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-16",
      "transaction_shares": "702",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "30075"
    },
    {
      "id": 305167,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "969",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "34792"
    },
    {
      "id": 305179,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "759",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "14230"
    },
    {
      "id": 305195,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-16",
      "transaction_shares": "298",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "4664"
    },
    {
      "id": 305238,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-16",
      "transaction_shares": "491",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "16265"
    },
    {
      "id": 350869,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-16",
      "transaction_shares": "304",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "48829"
    },
    {
      "id": 350873,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-16",
      "transaction_shares": "1054",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "49074"
    },
    {
      "id": 350889,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-16",
      "transaction_shares": "702",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "30075"
    },
    {
      "id": 350891,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "969",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "34792"
    },
    {
      "id": 350903,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "759",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "14230"
    },
    {
      "id": 350919,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-16",
      "transaction_shares": "298",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "4664"
    },
    {
      "id": 350962,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-16",
      "transaction_shares": "491",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "16265"
    },
    {
      "id": 398537,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-16",
      "transaction_shares": "304",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "48829"
    },
    {
      "id": 398541,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-16",
      "transaction_shares": "1054",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "49074"
    },
    {
      "id": 398557,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-16",
      "transaction_shares": "702",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "30075"
    },
    {
      "id": 398559,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "969",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "34792"
    },
    {
      "id": 398571,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "759",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "14230"
    },
    {
      "id": 398587,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-16",
      "transaction_shares": "298",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "4664"
    },
    {
      "id": 398630,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-16",
      "transaction_shares": "491",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "16265"
    },
    {
      "id": 228328,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "466",
      "transaction_price": "787.0",
      "transaction_type": "F",
      "shares_after_transaction": "49133"
    },
    {
      "id": 263947,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "466",
      "transaction_price": "787.0",
      "transaction_type": "F",
      "shares_after_transaction": "49133"
    },
    {
      "id": 305215,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "466",
      "transaction_price": "787.0",
      "transaction_type": "F",
      "shares_after_transaction": "49133"
    },
    {
      "id": 350939,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "466",
      "transaction_price": "787.0",
      "transaction_type": "F",
      "shares_after_transaction": "49133"
    },
    {
      "id": 398607,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "466",
      "transaction_price": "787.0",
      "transaction_type": "F",
      "shares_after_transaction": "49133"
    },
    {
      "id": 228274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2591",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17896"
    },
    {
      "id": 228279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-06",
      "transaction_shares": "907",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "5111"
    },
    {
      "id": 228282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "15263"
    },
    {
      "id": 228306,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "36253"
    },
    {
      "id": 228315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "31269"
    },
    {
      "id": 228320,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "50620"
    },
    {
      "id": 263887,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2591",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17896"
    },
    {
      "id": 263892,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-06",
      "transaction_shares": "907",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "5111"
    },
    {
      "id": 263895,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "15263"
    },
    {
      "id": 263920,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "36253"
    },
    {
      "id": 263930,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "31269"
    },
    {
      "id": 263936,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "50620"
    },
    {
      "id": 305155,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2591",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17896"
    },
    {
      "id": 305160,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-06",
      "transaction_shares": "907",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "5111"
    },
    {
      "id": 305163,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "15263"
    },
    {
      "id": 305188,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "36253"
    },
    {
      "id": 305198,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "31269"
    },
    {
      "id": 305204,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "50620"
    },
    {
      "id": 350879,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2591",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17896"
    },
    {
      "id": 350884,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-06",
      "transaction_shares": "907",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "5111"
    },
    {
      "id": 350887,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "15263"
    },
    {
      "id": 350912,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "36253"
    },
    {
      "id": 350922,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "31269"
    },
    {
      "id": 350928,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "50620"
    },
    {
      "id": 398547,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2591",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17896"
    },
    {
      "id": 398552,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-06",
      "transaction_shares": "907",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "5111"
    },
    {
      "id": 398555,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "15263"
    },
    {
      "id": 398580,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "36253"
    },
    {
      "id": 398590,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "31269"
    },
    {
      "id": 398596,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "50620"
    },
    {
      "id": 195404,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 228291,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 263905,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 305173,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 350897,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 398565,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 195453,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 228346,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 263966,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 305234,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 350958,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 398626,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 164790,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 164796,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 195393,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 195399,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 228276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 228285,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 263889,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 263898,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 305157,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 305166,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 350881,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 350890,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 398549,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 398558,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 136677,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 164821,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 195425,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 228316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 263932,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 305200,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 350924,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 398592,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-04",
      "transaction_shares": "1200",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "26272"
    },
    {
      "id": 136664,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 136671,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 164808,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 164815,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 195412,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 195419,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 228300,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 228308,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 263914,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 263922,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 305182,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 305190,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 350906,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 350914,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 398574,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-09-03",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 398582,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-03",
      "transaction_shares": "4",
      "transaction_price": "1166.52",
      "transaction_type": "S",
      "shares_after_transaction": "17778"
    },
    {
      "id": 136663,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 164807,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 195411,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 228299,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 263913,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 305181,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 350905,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 398573,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-08-28",
      "transaction_shares": "228",
      "transaction_price": "1204.79",
      "transaction_type": "S",
      "shares_after_transaction": "966"
    },
    {
      "id": 110503,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 110551,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136653,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 136705,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164797,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 164849,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 195400,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 195454,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 228287,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 228347,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 263900,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 263968,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 305168,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 305236,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 350892,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 350960,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 398560,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "10838",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "13010"
    },
    {
      "id": 398628,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-15",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110533,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 110542,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 136687,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 136696,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 164831,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 164840,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 195435,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 195444,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 228327,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 228337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 263946,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 263956,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 305214,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 305224,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 350938,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 350948,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 398606,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-13",
      "transaction_shares": "500",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "49599"
    },
    {
      "id": 398616,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-08-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 110529,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 136683,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 164827,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 195431,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 228323,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 263940,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 305208,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 350932,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 398600,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-08",
      "transaction_shares": "100",
      "transaction_price": "1081.83",
      "transaction_type": "S",
      "shares_after_transaction": "56096"
    },
    {
      "id": 110530,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 136684,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 164828,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 195432,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 228324,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 263941,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 305209,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 350933,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 398601,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-08-07",
      "transaction_shares": "487",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "4691"
    },
    {
      "id": 110506,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 110508,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136656,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 136658,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164800,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 164802,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 195403,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 195406,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 228290,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 228293,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 263904,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 263907,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 305172,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 305175,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 350896,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 350899,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 398564,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-08-02",
      "transaction_shares": "23638",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "74637"
    },
    {
      "id": 398567,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-02",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110495,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 110509,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 110526,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 136645,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 136659,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 136680,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 164787,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 164803,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 164824,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 195390,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 195407,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 195428,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 228272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 228294,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 228319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 263885,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 263908,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 263935,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 305153,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 305176,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 305203,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 350877,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 350900,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 350927,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 398545,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1100.03",
      "transaction_type": "S",
      "shares_after_transaction": "17782"
    },
    {
      "id": 398568,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "1",
      "transaction_price": "1053.22",
      "transaction_type": "S",
      "shares_after_transaction": "17881"
    },
    {
      "id": 398595,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-08-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 110536,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 136690,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 164834,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 195438,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 228331,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 263950,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 305218,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 350942,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 398610,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-07-11",
      "transaction_shares": "1866",
      "transaction_price": "1088.95",
      "transaction_type": "S",
      "shares_after_transaction": "37937"
    },
    {
      "id": 86280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 86309,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 110505,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 110541,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 136655,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 136695,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 164799,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 164839,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 195402,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 195443,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 228289,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 228336,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 263902,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 263955,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 305170,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 305223,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 350894,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 350947,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 398562,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-07-01",
      "transaction_shares": "1137",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14068"
    },
    {
      "id": 398615,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-01",
      "transaction_shares": "3",
      "transaction_price": "1047.11",
      "transaction_type": "S",
      "shares_after_transaction": "17979"
    },
    {
      "id": 64349,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 64356,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 86307,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 86315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 110539,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 110548,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 136693,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 136702,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 164837,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 164846,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 195441,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 195450,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 228334,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 228343,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 263953,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 263962,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 305221,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 305230,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 350945,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 350954,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 398613,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-24",
      "transaction_shares": "14450",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "50887"
    },
    {
      "id": 398622,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-24",
      "transaction_shares": "756",
      "transaction_price": "371.4",
      "transaction_type": "M",
      "shares_after_transaction": "2138"
    },
    {
      "id": 64318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 86274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 110498,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 136648,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 164791,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 195394,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 228277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 263890,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 305158,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 350882,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 398550,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-14",
      "transaction_shares": "1535",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "2917"
    },
    {
      "id": 64342,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 86299,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 110528,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 136682,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 164826,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 195430,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 228322,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 263938,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 305206,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 350930,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 398598,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-11",
      "transaction_shares": "7321",
      "transaction_price": "1015.28",
      "transaction_type": "S",
      "shares_after_transaction": "56877"
    },
    {
      "id": 64321,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64359,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86277,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110501,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110552,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136651,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136706,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164794,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164850,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 195397,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 195455,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 228281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 228348,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 263894,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 263969,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 305162,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 305237,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 350886,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 350961,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 398554,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "75799",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 398629,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-06-10",
      "transaction_shares": "1608",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64320,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 86276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 110500,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 136650,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 164793,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 195396,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 228280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 263893,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 305161,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 350885,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 398553,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-06-06",
      "transaction_shares": "787",
      "transaction_price": "1015.02",
      "transaction_type": "S",
      "shares_after_transaction": "64198"
    },
    {
      "id": 64338,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 86295,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 110523,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 136676,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 164820,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 195424,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 228314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 263929,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 305197,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 350921,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 398589,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-05",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 64330,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 64348,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 86287,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 86306,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 110515,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 110538,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 136667,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 136692,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 164811,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 164836,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 195415,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 195440,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 228303,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 228333,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 263917,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 263952,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 305185,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 305220,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 350909,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 350944,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 398577,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-03",
      "transaction_shares": "2",
      "transaction_price": "979.4",
      "transaction_type": "S",
      "shares_after_transaction": "18080"
    },
    {
      "id": 398612,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-06-03",
      "transaction_shares": "1138",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "14069"
    },
    {
      "id": 64334,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 86291,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 110519,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 136672,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 164816,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 195420,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 228309,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 263924,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 305192,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 350916,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 398584,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-28",
      "transaction_shares": "1172",
      "transaction_price": "625.60",
      "transaction_type": "M",
      "shares_after_transaction": "2554"
    },
    {
      "id": 44627,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 64344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 86301,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 110532,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 136686,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 164830,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 195434,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 228326,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 263943,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 305211,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 350935,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 398603,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-05-21",
      "transaction_shares": "1865",
      "transaction_price": "994.9",
      "transaction_type": "S",
      "shares_after_transaction": "34678"
    },
    {
      "id": 44632,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 64351,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 86310,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 110543,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 136697,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 164841,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 195445,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 228338,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 263957,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 305225,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 350949,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 398617,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-17",
      "transaction_shares": "22687",
      "transaction_price": "979.22",
      "transaction_type": "S",
      "shares_after_transaction": "467020"
    },
    {
      "id": 44615,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 64328,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 86285,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 110513,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 136665,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 164809,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 195413,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 228301,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 263915,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 305183,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 350907,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 398575,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-16",
      "transaction_shares": "907",
      "transaction_price": "967.4",
      "transaction_type": "S",
      "shares_after_transaction": "835476"
    },
    {
      "id": 44611,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 64324,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 86281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 110507,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 136657,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 164801,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 195405,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 228292,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 263906,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 305174,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 350898,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 398566,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "111",
      "transaction_price": "965.69",
      "transaction_type": "S",
      "shares_after_transaction": "886272"
    },
    {
      "id": 44636,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 64355,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 86314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 110547,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 136701,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 164845,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 195449,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 228342,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 263961,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 305229,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 350953,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 398621,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2024-05-13",
      "transaction_shares": "203204",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "577633"
    },
    {
      "id": 44609,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 64322,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 86278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 110502,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 136652,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 164795,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 195398,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 228283,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 263896,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 305164,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 350888,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 398556,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "2000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "28349"
    },
    {
      "id": 44631,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 44635,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 64350,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 64354,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 86308,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 86313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 110540,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 110546,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 136694,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 136700,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 164838,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 164844,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 195442,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 195448,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 228335,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 228341,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 263954,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 263960,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 305222,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 305228,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 350946,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 350952,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 398614,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-05-01",
      "transaction_shares": "250",
      "transaction_price": "889.41",
      "transaction_type": "S",
      "shares_after_transaction": "12931"
    },
    {
      "id": 398620,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "3",
      "transaction_price": "889.5",
      "transaction_type": "S",
      "shares_after_transaction": "18179"
    },
    {
      "id": 44628,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 64345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 86302,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 110534,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 136688,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 164832,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 195436,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 228329,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 263948,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 305216,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 350940,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 398608,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-04-29",
      "transaction_shares": "36296",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 27642,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 27658,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 44613,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 44634,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 64326,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 64353,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 86283,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 86312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 110511,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 110545,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 136661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 136699,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 164805,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 164843,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 195409,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 195447,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 228296,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 228340,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 263910,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 263959,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 305178,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 305227,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 350902,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 350951,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 398570,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-04-01",
      "transaction_shares": "250",
      "transaction_price": "964.73",
      "transaction_type": "S",
      "shares_after_transaction": "13181"
    },
    {
      "id": 398619,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-01",
      "transaction_shares": "2",
      "transaction_price": "957.78",
      "transaction_type": "S",
      "shares_after_transaction": "18280"
    },
    {
      "id": 14702,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 27659,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 44637,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 64357,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 86316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 110549,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 136703,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 164847,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 195451,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 228344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 263964,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 305232,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 350956,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 398624,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 14691,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 14698,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 27647,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 27654,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 44619,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 44626,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 64333,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 64343,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 86290,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 86300,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 110518,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 110531,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 136670,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 136685,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 164814,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 164829,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 195418,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 195433,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 228307,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 228325,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 263921,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 263942,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 305189,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 305210,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 350913,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 350934,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 398581,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 398602,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 14681,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 14682,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 14683,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 14688,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 27636,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 27637,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 27638,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 27644,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 44604,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 44605,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 44606,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 44616,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 64314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 64315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 64316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 64329,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 86270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 86271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 86272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 86286,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 110493,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 110494,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 110496,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 110514,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 136643,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 136644,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 136646,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 136666,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 164785,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 164786,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 164788,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 164810,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 195388,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 195389,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 195391,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 195414,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 228270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 228271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 228273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 228302,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 263882,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 263883,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 263886,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 263916,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 305150,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 305151,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 305154,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 305184,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 350874,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 350875,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 350878,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 350908,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 398542,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 398543,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 398546,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 398576,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14686,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 14690,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 27641,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 27646,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 44612,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 44618,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 64325,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 64332,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 86282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 86289,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 110510,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 110517,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 136660,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 136669,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 164804,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 164813,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 195408,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 195417,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 228295,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 228305,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 263909,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 263919,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 305177,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 305187,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 350901,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 350911,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 398569,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 398579,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 4668,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 14693,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 27649,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 44621,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 64336,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 86293,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 110521,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 136674,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 164818,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 195422,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 228311,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 263926,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 305194,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 350918,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 398586,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 4666,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 14689,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 27645,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 44617,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 64331,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 86288,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 110516,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 136668,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 164812,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 195416,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 228304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 263918,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 305186,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 350910,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 398578,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 4671,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 4675,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 14696,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 14701,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 27652,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 27657,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 44624,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 44633,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 64340,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 64352,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 86297,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 86311,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 110525,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 110544,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 136679,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 136698,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 164823,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 164842,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 195427,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 195446,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 228318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 228339,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 263934,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 263958,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 305202,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 305226,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 350926,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 350950,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 398594,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 398618,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 4676,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14703,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 27660,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 44638,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 64358,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 86317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 110550,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 136704,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 164848,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 195452,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 228345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 263965,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 305233,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 350957,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 398625,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 4670,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 4677,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 14695,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 14704,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 27651,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 27661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 44623,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 44639,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 64339,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 64360,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 86296,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 86319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 110524,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 110553,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 136678,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 136707,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 164822,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 164851,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 195426,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 195456,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 228317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 228350,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 263933,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 263972,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 305201,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 305240,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 350925,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 350964,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 398593,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 398632,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 4662,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 14680,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 27635,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 44603,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 64313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 86269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 110492,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 136642,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 164784,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 195387,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 228268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 263879,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 305147,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 350871,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 398539,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 4664,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 4669,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 14685,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 14694,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 27640,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 27650,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 44608,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 44622,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 64319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 64337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 86275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 86294,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 110499,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 110522,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 136649,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 136675,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 164792,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 164819,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 195395,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 195423,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 228278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 228313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 263891,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 263928,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 305159,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 305196,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 350883,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 350920,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 398551,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 398588,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 4661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 4663,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 14679,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 14684,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 27634,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 27639,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 44602,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 44607,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 64312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 64317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 86268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 86273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 110491,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 110497,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 136641,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 136647,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 164783,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 164789,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 195386,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 195392,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 228267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 228275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 263878,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 263888,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 305146,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 305156,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 350870,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 350880,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 398538,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 398548,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 4674,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 14700,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 27656,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 44630,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 64347,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 86305,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 110537,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 136691,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 164835,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 195439,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 228332,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 263951,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 305219,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 350943,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 398611,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 4667,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 14692,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 27648,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 44620,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 64335,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 86292,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 110520,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 136673,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 164817,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 195421,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 228310,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 263925,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 305193,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 350917,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 398585,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 4665,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 4672,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 4673,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 14687,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 14697,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 14699,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 27643,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 27653,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 27655,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 44614,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 44625,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 44629,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 64327,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 64341,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 64346,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 86284,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 86298,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 86303,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 110512,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 110527,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 110535,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 136662,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 136681,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 136689,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 164806,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 164825,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 164833,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 195410,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 195429,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 195437,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 228298,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 228321,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 228330,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 263912,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 263937,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 263949,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 305180,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 305205,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 305217,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 350904,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 350929,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 350941,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 398572,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 398597,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 398609,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 44610,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 64323,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 86279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 110504,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 136654,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 164798,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 195401,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 228288,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 263901,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 305169,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 350893,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 398561,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    }
  ]
}